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1. Introduction 
Tako-Tsubo cardiomyopathy (TTC), first described in 1990 by Sato in Japan (Sato et al., 
1990), has recently gained increasing consideration when reported in non-Japanese patients, 
including the United States and Europe (Hachamovitch et al., 1995; Sharkey et al., 2005; 
Desmet et al., 2003; Bybee et al., 2004; Dec, 2005; Kurowski et al., 2007) 
Typical presentation mimics acute coronary syndrome, with acute chest pain and/or 
dyspnoea, associated to electrocardiographic changes and moderate cardiac biomarkers 
release, but in which coronary angiography reveals no coronary arteries lesions. 
Echocardiography and left ventriculography show the characteristic abnormalities: a 
reversible left ventricle systolic dysfunction (Pilgrim et al., 2008; Prasad et al., 2008; Wittstein 
et al., 2005). These transient regional wall motion abnormalities, involving typically the left 
ventricle, usually extend beyond a single vessel territory (Sato et al., 1990; Dote et al., 1991). 
An expert consensus panel proposes a definition of TTC: “TTC is a recently described 
clinical entity characterised by acute but rapidly reversible left ventricle systolic dysfunction 
in the absence of atherosclerotic coronary artery disease, triggered by profound 
psychological stress. This distinctive form of ventricular stunning typically affects elderly 
women and preferentially involves the distal portion of the left ventricle chamber (apical 
ballooning), with the basal left ventricle hypercontractile. Although presentation often 
mimics ST-segment Elevation Myocardial Infarction, outcome is favourable with 
appropriate medical therapy” (Maron et al., 2006). 
The classical, first described, variant of TTC manifests as ballooning of the apical segment 
and compensatory hypercontraction of the middle-to-basal segments of the left ventricle 
during systole, similar to the Japanese octopus-trap pot, called Tako-Tsubo (Sato et al., 1990; 
Dote et al., 1991). Several variants of TTC have been reported recently, involving any part of 
the heart, but most commonly the left ventricle (Hahn et al., 2007; Kurowski et al., 2007; 
Pilliere et al., 2006; Reuss et al., 2007; Hurst et al., 2006). 
The incidence of TTC, also known as stress-induced cardiomyopathy, transient apical 
ballooning or broken heart syndrome, is estimated to be present in 1.7% to 2.2% of the 
patients with suspected acute coronary syndrome (Wittstein et al., 2005; Akashi et al., 2010; 
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Pavin et al., 1997; Brandspiegel et al., 1998; Flavahan 2006). TTC typically occurs in 
postmenopausal women, with a mean age ranged between 58 to 75. The condition is 
frequently precipitated by emotional or physical stress but a triggering event may not be 
identified (Bybee et al., 2004; Gianni et al., 2006).  
Prognosis is good, in contrast to acute coronary syndrome, provided that the patients 
survive the possible life-threatening acute presentation, with correction of the left ventricle 
dysfunction within several days or weeks (Bybee et al., 2004; Gianni et al., 2006; Nef et al., 
1993; Prasad et al., 2008; Krishnan et al., 2009; Pernicova et al., 2010).  
 
 
Table 1. Search strategy and review criteria. 
2. Clinical Features 
2.1 Clinical presentation 
The clinical presentation of TTC is similar to an acute coronary syndrome, usually 
indistinguishable from an acute coronary syndrome and resembling an ST Elevation 
Myocardial Infarction. Acute phase includes substernal chest pain and/or dyspnoea 
(Bybee et al., 2004; Gianni et al., 2006). 70 to 90% of the patients exhibit chest pain at rest, 
referring it as the most common symptom. Mild to moderate congestive heart failure is 
common. Non specific symptoms including syncope, weakness and nausea have also been 
reported (Hurst et al., 2010). Moreover, few patients were described as asymptomatic, 
often admitted for non cardiac illnesses, and TTC was suspected on electrocardiogram or 
cardiac biomarkers.  
Life-threatening initial symptoms are uncommon and out-hospital cardiac arrest due to 
cardiac rupture has also been very rarely recorded (Akashi et al., 2004; Ohara et al., 2005). 
However, hemodynamic compromise may occur, related to acute complications such as 
ventricular tachycardia, ventricular fibrillation, severe congestive heart failure or left 
ventricular outflow tract obstruction (Valbusa et al., 2008; Prasad et al., 2008). 
2.2 Population 
The cardiomyopathy usually affects women over 50 years of age, with a mean age ranged 
between 58 to 75 years, with approximately 3% of the cases in patients under 50 years of age 
(Prasad et al., 2008). TTC was rarely described in the male population, representing less than 
10% of all the cases (Bybee et al., 2004; Tsuchihashi et al., 2001; Sharkey et al., 2005; Akashi et 
al., 2008; Kurowski et al., 2007). In this population, cardiac risk factors seem to be less 
described, whereas highest prevalence of anxiety or depression was reported (Kurowski et 
al., 2007; Vidi et al., 2009; Mudd et al. 2007; Pace et al., 2011).  
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2.3 Incidence 
TTC is an infrequent cardiomyopathy, representing 0,7 to 2,2% of the patients with 
suspected acute coronary syndrome admitted to the hospital (Wittstein et al., 2005; Akashi et 
al., 2010; Pavin et al., 1997; Brandspiegel et al., 1998; Flavahan, 2006; Bybee et al., 2004; 
Gianni et al., 2006). A similar prevalence was reported from a registry of patients with 
troponine-positive acute coronary syndrome (Kurowski et al., 2007). The annual incidence of 
TTC was estimated to be 0,00006 to 0,05% (Klinčeva et al., 2007; Pilliere et al., 2006). 
Recently, Italian multicenter studies have showed a variation in TTC occurrence with a 
summer and morning peak. Moreover, they have also described a weekly variation with a 
significant Monday peak in the working population (Manfredini et al., 2010; Gallerani et al., 
1992). However, other series found differing results in terms of peak of occurrence 
(Mansencal et al., 2010). 
3. Precipitating events 
3.1 Preceding stressful event 
A main feature of the TTC is that it usually follows an identifiable emotional or a physical 
stressful event. This condition is found in approximately two thirds of the TTC patients 
(Sharkey et al., 2010; Elesber et al., 2007; Gianni et al., 2006).  
In the case of seasonal, weekly, circadian variations of TTC occurrence, stress caused by 
resuming working activities after a break was suggested as a triggering factor (Manfredini et 
al., 2010). A recent study has showed that in TTC patients, a high-anxiety trait is common 
but not significantly higher as compared with ST Elevation Myocardial Infarction patients. 
Moreover high-anxiety trait is not a predictor of TTC in patients with suspected acute 
coronary syndrome (Pace et al., 2011).  
3.2 Emotional stressful event 
Numerous emotional factors have been noted: being informed of the death of a loved one, 
receiving tragic news, public speaking, heated argument, marital discord, spousal 
departure, accidents and financial loss, unexpected bill, surprise birthday party, babysitting 
grandchildren, assault, loved one hospitalisation, car accident, catastrophic medical 
diagnosis, jellyfish sting, natural disaster: earthquarke, Xynthia tempest (Bielecka-Dabrowa 
et al., 2010; Wittstein et al., 2005 ; Watanabe et al., 2005; Hurst et al., 2010; Bybee et al., 2004; 
Parodi et al., 2007; Prasad et al., 2008; Sharkey et al., 2005; Trebouet et al., 2011; Movaheda et 
al., 2007, Montassier et al., 2009). 
3.3 Physical stressful event 
3.3.1 General anesthesia 
Numerous cases of TTC related to general anesthesia have been described, involving 
various surgical procedures such as digestive surgery (cholecystectomy, hepatectomy, 
colectomy, hernia repair), cardiothoracic surgery, orthopedic surgery, eye surgery. In such 
cases, several mechanisms may represent the triggering event: preoperative anxiety, stress 
of surgery, induction of anesthesia, laryngoscopy, perioperative hemodynamic instability, 
perioperative administration of vasopressors agents, extubation, and postoperative pain 
(Liu et al., 2010; Lentschener et al., 2006; Gavish et al., 2006; Takayama et al., 2004; Liu S et 
al., 2008; Ramakrishna et al., 2005; Takigawa et al., 2003; Mizutani et al., 2002; Itoh H et al., 
2007; Littlejohn et al., 2008; Jabaudon et al., 2007). 
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3.3.2 Other physical stressful events 
Gastrointestinal triggers have been commonly reported (high-intensity vomiting, 
diverticulitis, pelvic abscess, acute cholecystitis, pancreatitis, pseudomembranous colitis) 
but other physical stressful event have been showed to act as triggering events, such as 
cardiac stress test, severe pain, asthma or chronic obstructive airway exacerbation, sepsis, 
acute intracranial events (intracranial bleeding, head trauma, ischemic stroke, epileptic 
seizure), thyrotoxicosis (Dorfmann al., 2007; Rossor et al., 2007; Ionescu et al., 2010; Sharkey 
et al., 2005; Bybee et al., 2004; Gianni et al., 2005; Rajani et al., 2010).  
Several cases have been reported after administration of pharmacologic agents: beta-agonist 
bronchodilator, epinephrine, norepinephrine, dobutamine. All these are exogenous 
cathecolaminergic agents (Abraham et al., 2009; Cherian et al., 2008; Winogradow et al. 
2011). Several cases have been noted to be connected to cocaine use, opiate withdrawal or 
excessive alcohol consumption (Daka et al., 2007; Rivera et al., 2006).  
TTC has also been described following a normal vaginal delivery or after caesarean delivery 
(Teh et al., 2010; Zdanowicz et al., 2011; Citro et al., 2010; Crimi, 2008; Muller et al., 2007; 
Parodi et al., 2007; Hawthorne et al., 1997). These cases in premenopausal women highlight 
the potential role of estrogens in TTC etiopathogenesis and the interaction of the latter with 
catecholamines. 
Recently, several cases have been reported in postmenopausal women underlying 
malignancies (Fazio et al., 2010; Abe et al., 2003; Kawai et al., 2000). In these conditions, 
precipitating factors could be the context of a stressor or paraneoplastic phenomenon, but 
the link remains unclear.  
4. Electrocardiogram and cardiac biomarkers 
4.1 Electrocardiogram findings 
As clinical presentation, TTC is indistinguishable from an acute coronary syndrome based on 
ECG analysis and ECG findings may vary at presentation. Most frequently, the ECG 
characteristics of the TTC are consistent with ST-segment elevation, mimicking an ST-elevation 
myocardial infarction, typically in the anterior precordial leads (Bybee et al., 2007; Ogura et al., 
2003; Kurisu et al., 2004; Tsuchihashi et al., 2001). Inferior or lateral leads could also be 
involved. ST-segment is reported in approximately 30 to 50% of the TCC patients (Sharkey et 
al. 2010; Abe et al., 2003; Akashi et al., 2005; Kurisu et al., 2002; Elesber et al., 2007; Sato et al., 
2006; Tsuchihashi et al., 2001; Dib et al., 2009). Moreover, transient ST-segment isolated 
elevation in lead aVR has also been described in the TTC patients (Rostoff et al., 2009).  
The next most common ECG characteristic in TTC are deep T wave inversions, especially in 
precordial leads, and frequently associated with corrected QT interval prolongation. These 
ECG abnormalities have been reported in several series (Krishnan et al., 2009; Kim et al., 2010; 
Silva et al., 2009). Furthermore, these corrected QT interval prolongations have been noted to 
be correlated with highest occurrence of ventricular fibrillation and extent of wall motion 
abnormalities in acute coronary syndrome patients (Yunus et al., 1996; Stajer et al., 1993).  
Transient pathological Q waves may rarely develop in TTC patients (Rostoff et al., 2009; 
Krishnan et al., 2009; Kim et al., 2010; Silva et al., 2009). Moreover, a new bundle-branch 
block or a normal ECG may be found at presentation (Prasad et al., 2008; Bybee et al,. 2007; 
Ogura et al.,  2003; Kurisu et al., 2004; Tsuchihashi et al., 2001; Sharkey et al. 2010).  
Atrial and ventricular arrhythmias may occur, but ventricular tachycardia and fibrillation 
are rarely reported, occurring in 1% to 6% of the patients (Matsuoka et al., 2003; Denney et 
www.intechopen.com
Tako-Tsubo Cardiomyopathy: 
A Recent Clinical Syndrome Mimicking an Acute Coronary Syndrome 
 
107 
al., 2005; Bonello et al., 2008). Moreover, despite the frequent corrected QT interval 
prolongation, the occurrence of torsades de pointes is rarely described (Elkhateeb et al., 
2008; Dib et al., 2008).  
4.2 Cardiac biomarker 
The majority of the patients had a moderate cardiac troponin T release, with a peak within 24 
hours (Sharkey et al., 2005; Bybee et al., 2004; Desmet et al., 2003). The discrepancy between the 
minor elevation in cardiac biomarkers and the extent of the wall motion abnormities is a 
hallmark of the TTC (Prasad et al., J 2008; Kurisu et al., 2004). Thus, this modest rise in cardiac 
biomarker may possibly help to distinguishes it from acute coronary syndrome. 
Brain Natriuretic Peptide level is usually elevated. Furthermore, its rise, higher than that the 
one seen in acute coronary syndrome, is purely correlated with the left ventricle systolic 
dysfunction (Akashi et al., 2004).  
5. Coronary angiography and cardiac imaging 
As the clinical features of TTC are indistinguishable from the acute coronary syndrome, 
TTC, defined as a reversible left ventricle systolic dysfunction, may be diagnosed by 
coronary angiogram, echocardiography or cardiac magnetic resonance (Pilgrim et al., 2008; 
Prasad et al., 2008; Sharkey et al., 2005; Wittstein et al., 2005).  
Classically, at presentation, transthoracic echocardiography and left ventriculography show 
the characteristic regional wall motion abnormalities involving hypokinesis or akinesis of 
apex and mid segments of the left ventricle with hyperkinesis in basal segment.  
Thus, the classical abnormality is revealed as an apical ballooning of the apex with systole, 
in the shape resembling to a traditional Japanese jar used for catching octopus, which was 
named “Takotsubo”. The name of the syndrome is derived from this fisherman’s device 
(Sato et al., 1990; Dote et al., 1991; Pilgrim et al., 2008; Pilgrim et al., 2008; Prasad et al., 2008; 
Sharkey et al., 2005; Wittstein et al., 2005).  
5.1 Echocardiography 
Clearly, the widespread use of echocardiography, especially in critical care patients, is 
responsible for the recent increased frequency of TTC recognition (Sharkey et al., 2005; Park 
et al., 2005; Haghi et al., 2006). However, in the acute phase, echocardiography may not help 
to distinguish TTC from acute coronary syndrome in view of regional wall motion 
abnormalities. Thus, diagnosis is frequently made by cardiac catheterization (Bybee et al., 
2004; Hurst et al., 2010).  
5.2 Coronary angiography 
It is worth noticing that the wall motion abnormalities involving more than one particular 
coronary artery territory are a hallmark of TTC (Prasad et al., 2008; Krishnan et al., 2009). 
This TTC characteristic is most frequently identified during left ventriculography. 
Moreover, in patients with TTC, coronary angiography shows normal coronary arteries or 
coronary arteries with no significant disease (<50% luminal stenosis) (Pilgrim et al., 2008; 
Prasad et al., 2008; Sharkey et al., 2005; Bybee et al., 2004; Gianni et al., 2006). Thus, when the 
coronary anatomy is free of significant atherosclerotic lesions with wall motion 
abnormalities of the left ventricle, usually of the apex, and unrelated to a single coronary 
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artery territory, the diagnosis of TTC may be postulated. As the patients are supposed to 
suffer from an acute coronary syndrome, the diagnosis of TTC is currently made during left 
ventriculography, showing the typical regional wall motion abnormalities. 
In the acute phase, severe left ventricle systolic dysfunction is frequently noted, with 
ejection fraction decreasing from 10% to 30%. In a review of several series, the mean ejection 
fraction ranged from 20 to 49% (Bybee et al., 2004; Gianni et al., 2006). 
 
 
Fig. 1. Echocardiography showing hypokinesis of the apex with hyperkinesis of the base of 
the left ventricle.  
Several variants of TTC have been described, related to a variety of angiographic 
presentations, involving different areas of the left ventricle. Indeed, based on anatomic 
location, four different types of TTC are described in literature. All these patients have 
initially the same clinical presentation. The classic type, previously reported, is described as 
apical ballooning, with depressed contractile function of the mid and apical segment of the 
left ventricle and with compensatory hyperkinesis of the basal segments. This type is the 
most encountered in literature (Bybee et al., 2004; Gianni et al., 2006; Prasad et al., 2008; Abe 
et al., 2003). The second type is the reverse type in which patients present hyperdynamic 
apex, with hypokinesis or akinesis of the basal left ventricle segments. Given its distinct 
basal involvement with apical and mid-ventricular sparing, this type of TTC was considered 
to be atypical or inverted (Van de Walle et al., 2006; Abdulla et al., 2006; Mansencal et al., 
2010). In a recent study, its prevalence was estimated to be 24% of all left ventricle variants 
of TTC (Mansencal et al., 2010). The third type involves the mid left ventricle wall, with 
sparing of the basal and apical segments. It is also called “midventricular ballooning” 
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(Ohtsubo et al., 2005; Hurst et al., 2006; Tamura et al., 2007; Yasu et al., 2006). The fourth 
type is characterised by a localized wall motion abnormality affecting a segment of the left 
ventricle wall, usually the anterior wall (Suzuki et al., 2004; Lamm et al., 2007; Mazzarotto et 
al., 2005; Strunk et al., 2006). These variants of TTC have similar prognoses.  
Furthermore, involvement of the right ventricle is commonly associated to left ventricle 
systolic dysfunction in TTC, revealed in 30% of the patients (Elesber et al., 2006; Haghi et al., 
2006; Novak et al., 2007). In these patients, the presence of right ventricle dysfunction seems  
 
 
 
Fig. 2. Ventriculography in systole showing apical ballooning. 
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to be associated with worse left ventricle systolic dysfunction, longer hospitalization and a 
higher possibility of development of severe complications, particularly occurrence of 
congestive heart failure (Prasad et al., 2008; Silva et al., 2009; Elesber et al., 2006; Haghi et al., 
2006; Novak et al., 2007; Nef et al. 2010). A report described a case of TTC characterized by 
biventricular ballooning, pulmonary hypertension and hemodynamic compromise 
associated with prolonged hospitalisation, highlighting the fact that initial management 
should evaluate left ventricle function but also detect right ventricle involvement (Citro et 
al., 2010). In another series, association between right ventricle involvement and lower 
ejection fraction has not been shown (Teh et al., 2010). However, this condition should be 
immediately known as it possibly impacts outcome. 
5.3 Cardiac magnetic resonance 
Cardiac magnetic resonance is interesting in order to appreciate the extent of the regional 
wall motion abnormalities and the variety of depressed contractile function patterns. TTC is 
characterized by lack of delayed hyper-enhancement following gadolinium injection. Thus, 
this procedure may help differentiate TTC from acute coronary syndrome or myocarditis 
(Mitchell et al., 2007; Deetjen et al., 2006). Furthermore, cardiac magnetic resonance is the 
most accurate procedure in order to assess the right ventricle involvement in the 
cardiomyopathy (Haghi et al., 2007; Sharkey et al., 2010; Haghi et al., 2006). In addition, 
cardiac magnetic resonance may help identify ventricular thrombi not visualised by 
echocardiography (Sharkey et al., 2010). Thus, cardiac magnetic resonance is the best 
diagnosis procedure after the acute phase, when the patient’s condition is stabilised. 
 
 
Fig. 3. Cardiac magnetic resonance image showing preserved contraction of the base of the 
ventricle and apical ballooning. 
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6. Diagnosis  
Two guidelines have been proposed for the diagnosis of TTC, based on a consensus of 
experts, because there is no diagnosis test of the condition. The first one was proposed by 
the Mayo Clinic in the United States and the other by the Tako-Tsubo Cardiomyopathy 
Study Group in Japan (Bybee et al., 2004; Prasad et al., 2007; Kawai et al., 2007).   
The Mayo Clinic proposed criteria for the diagnosis of TTC included: (1) new 
electrocardiographic abnormalities (either ST-segment elevation or T wave inversion) or 
modest elevation in cardiac troponin, (2) transient hypokinesis, akinesis or dyskinesis of the 
LV mid segments with or without apical involvement, with wall motion abnormalities 
extending beyond a single epicardial vascular distribution, with a stressful triggering factor 
often, but not always, present, (3) absence of obstructive coronary disease or angiographic 
evidence of plaque rupture, (4) absence of pheochromocytoma or myocarditis.  
The Mayo Clinic criteria were initially proposed by Bybee et al. and were secondly revised 
by Prasad et al (Bybee et al., 2004; Prasad et al., 2007). In the second modified version of the 
criteria for TTC, patients with intracranial bleeding were no longer excluded, including 
those with subarachnoid haemorrhage (Prasad et al., 2007).  
For its part, the Japanese guideline calls the apical ballooning seen in cerebrovascular accidents 
and pheochromocytoma a Tako-Tsubo-like myocardial dysfunction (Kawai et al., 2007).  
These guidelines include the different variants of TTC. Moreover, the most important 
feature of TTC is a documented correction of the ejection fraction. Thus, diagnosis of TTC 
may only be concluded after the recovery of the transient left ventricle systolic dysfunction, 
not only based on criteria at time of presentation.  
 
 
Table 2. Mayo Clinic proposed criteria for the diagnosis of Tako-Tsubo cardiomyopathy. 
7. Diagnosis strategy  
The differential diagnosis with an acute coronary syndrome is not yet possible in the acute 
phase based on clinical or laboratory features. Thus, the diagnosis should be considered in 
postmenopausal women, presenting with chest pain and/or dyspnoea, with no or few risk 
factors for coronary artery disease and history of recent stress associated to 
electrocardiographic abnormalities and a moderate cardiac troponin T release. Furthermore, 
the diagnosis should also be suspected in inpatients, especially in the intensive care unit 
population, with acute left ventricle systolic dysfunction associated to hemodynamic 
compromise, pulmonary oedema, electrocardiographic abnormalities consistent with an 
acute coronary syndrome or a cardiac troponin T release (Elesber et al., 2006; Haghi et al., 
2006; Novak et al., 2007). 
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The diagnosis of TTC is most frequently made during coronary angiography, performed as 
recommended by guidelines for the management of acute coronary syndrome. In fact, 
patients with TTC, due to their initial presentation similar to an acute coronary syndrome, 
are usually referred for urgent reperfusion therapy. The absence of fixed epicardial coronary 
artery disease and no angiographic evidence of plaque rupture or intracoronary thrombus 
formation associated with characteristic regional wall motion abnormality, as previously 
described, leads to the diagnosis. Thus, in patients with TTC, coronary angiography shows 
normal coronary arteries or coronary arteries with no significant disease (<50% luminal 
stenosis). However, few patients exhibit a concomitant obstructive coronary artery disease 
in witch case cardiac magnetic resonance may be useful to distinguish TTC from acute 
coronary syndrome (Hoyt et al., 2009; Deetjen et al., 2006).  
As briefly indicated above, in case of typical presentation of TTC, in a postmenopausal 
woman with chest pain related to a stressful event with no or few risk factors for coronary 
artery disease, coronary angiography should be considered as the first choice. Indeed, these 
patients may be exposed to inappropriate therapy such as thrombolysis, which may lead to 
serious complications, especially in this classical aged population (Kolkebeck et al., 2008). 
Thus, a good strategy seems to be to transfer a patient suspected of TTC to a cardiac 
catheterization laboratory for emergency coronary angiography and avoid the 
administration of fibrinolytic therapy. However, suspicion of the diagnosis of TTC is not 
sufficient to contraindicate fibrinolytic therapy if needed, as the great majority of patients 
with a ST-segment Myocardial Infarction will have an obstructive coronary disease. 
Basically, guidelines recommended managing these patients as usual, with urgent cardiac 
catheterization or with fibrinolytic therapy (Prasad et al., 2008; Reeder et al., 2010).  
The diagnosis of TTC without cardiac catheterization is difficult and coronary angiography 
should be rapidly performed. Indeed, echocardiography realised in the acute phase may not 
help to distinguish the regional wall motion abnormalities of TTC from acute coronary 
syndrome, even if in case of TTC, the wall motion abnormalities involve more than one 
particular coronary artery territory. Moreover, the variants of the classical TTC pattern are 
harder to diagnose by echocardiography alone. However, sometimes, patients are 
contraindicated to undergo invasive strategy. In these patients, repeated echocardiography 
allows for the documentation of the correction of the left ventricle systolic dysfunction 
(Anand et al., 2010).  
8. Complications  
In the acute phase, complications may occur and life-threatening presentation is not rare. 
Indeed, acute complications have been shown in approximately 20% of the patients (Bybee 
et al., 2004; Bonello et al., 2008). Most of them are related to left ventricular heart failure, 
reported as follows (prevalence): pulmonary oedema (15%), cardiogenic shock (6,5%), left 
ventricle outflow tract obstruction (11%), mitral regurgitation (25%), ventricular mural 
thrombus formation (7%) (Pernicova et al., 2010; Donohue et al., 2005; Akashi et al., 2004; 
Nef et al., 2006; Nef al., 2009; Bonello al., 2008; Barrera-Ramirez et al., 2003; Zaroff et al.,  
2000). In case of left ventricular thrombus formation, thromboembolic complications, such 
as stroke, occur in 0,8% of the patients (de Gregorio et al., 2008).  
Arrhythmias are also described, including atrial or ventricular arrhythmias. Incidence of 
atrial fibrillation has been quoted at 15%, ventricular tachycardia at 1,6% (Bielecka-Dabrowa 
et al., 2010; Ionescu et al., 2010). QT prolongation resulting in torsades de pointes is a 
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potential mechanism for ventricular arrhythmias (Bonello et al., 2008). This condition is 
involved in a large proportion of the syndrome mortality rate, as sudden cardiac death due 
to ventricular fibrillation was estimated to be 4% (Ionescu et al., 2010).      
Other rare complications have been noted such as pneumothorax or left ventricular rupture 
(Bielecka-Dabrowa et al., 2010; Matsuoka et al., 2000; Sakai et al., 2005; Ohara et al., 2005). A 
TTC complicated by a ventricular septal dissection with a concomitant septal performation 
have been recently reported (Mariscalco et al., 2010). This patient never recovered a normal 
left ventricular systolic function. Furthermore, increase risk of bleeding has been noted 
secondary to anticoagulation prescribed in case of left ventricular thrombus formation or in 
case of inappropriate thrombolysis.  
9. Prognosis and recurrence 
9.1 Prognosis 
Prognosis is favourable, provided that the patients survive the possible life-threatening 
acute phase, with full recovery of the left ventricular systolic function within several weeks, 
typically within 1 to 4 weeks (Bybee et al., 2004; Gianni et al., 2006; Nef et al., 2007; Prasad et 
al., 2008; Pernicova et al., 2010). Therefore, the correction of the left ventricle systolic 
dysfunction and the correction of the regional wall motion abnormalities during the 
electrocardiographic follow-up is a hallmark of the cardiomyopathy. However, a recent 
study has showed a more important delay in the correction of the left ventricular systolic 
dysfunction, with a normalisation in 2.5 to 12 months in 5% of their included patients 
(Sharkey et al., 2010).  
As mentioned before, severe acute presentation may occur and in-hospital mortality rate 
is estimated to be 1.1% to 2%, mostly related to arrhythmias or mechanical complications 
(Mariscalco et al., 2010). Thus, this data highlight the fact that TTC is not entirely benign 
and that TTC may require early and aggressive management. In several reviews, long-
term survival seems to be similar to the one expected in the general population (Elesber, 
et al., 2006; Gianni et al., 2006). Late sudden death is particularly uncommon (Fineschi et 
al., 2010). However, a recent study has showed that survival, in two-third of the patients 
with TTC, was worst than in the general age- and sex-matched population. In their 
patients, mortality has always been related to noncardiac diseases, and for the authors, 
TTC may be a marker for impaired health (Sharkey et al., 2010).  Another study found that 
the long-term mortality rate was higher than the long-term mortality rate in the general 
population and mostly due to patients’ comorbidities. Moreover, in this study, the 
severity of the initial presentation was not correlated to long-term outcome (Parodi et al., 
2010). Thus, long-term outcome remains unclear in patients with TTC and larger studies 
are needed to confirm these recent findings.  
9.2 Recurrence 
As noted in several reviews, 3.5% to 10% of the patients have a recurrence during the first 
few years after the initial presentation (Bybee et al., 2004; Gianni et al., 2006; Nef et al., 2007; 
Prasad et al., 2008). A recent 4-year follow-up study described 11.4% recurrence of TTC 
(Elesber et al., 2007). Published data has also showed that the different variants of TTC may 
differ on recurrence (Blessing et al. 2007). This recurrence occurs in particularly similar 
circumstances, highlighting the importance to educate the patients in order to banish stress 
or physical triggering factors (Sharkey et al., 2010). Furthermore, chest pain and dyspnoea 
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recurrence occurs frequently. Indeed, a study indicated a rate of rehospitalisation for cardiac 
complaints estimated at 30% (Ionescu et al., 2010).   
10. Treatment 
10.1 Acute phase 
In the acute phase, the treatment of TTC is empirical and mainly supportive, adapted on 
clinical presentation (Prasad et al., 2008). The objective is to correct the left ventricle systolic 
dysfunction with standard medication for left ventricle systolic dysfunction. Moreover, as 
the differential diagnosis with an acute coronary syndrome is not initially possible, data 
suggest starting usual treatment for acute coronary syndrome, suspended upon 
confirmation of the diagnosis (Prasad et al., 2008; Silva et al., 2009).  
Thus, initial management consists in administration of β-blockers, angiotensinconverting 
enzyme inhibitors, aspirin and heparin. Congestive heart failure is treated by diuretics 
(Bybee et al., 2004; Gianni et al., 2006). β-blockers are recommended in patients with left 
ventricle outflow tract obstruction and are contraindicated in case of congestive heart failure 
with low ejection fraction, hypotension or bradycardia. For their part, angiotensin-
converting enzyme inhibitors are recommended in patients without a left ventricle outflow 
tract obstruction. The duration of the treatment remains unclear but it is commonly accepted 
to continue the treatment until the full recovery of the left ventricle systolic function.  
10.1.1 Hemodynamic compromise 
In the case of hemodynamic compromise due to pump failure, the use of an intra-aortic 
balloon pump is better than the use of inotropic agents, as these are known to enhance left 
ventricle outflow tract obstruction (Previtali et al., 2005). Therefore, echocardiography has to 
be done upon presentation in order to detect left ventricle outflow tract obstruction 
(Tsuchihashi et al., 2001; Bybee et al., 2004). In patients with hypotension due to pump 
failure without significant left ventricle outflow tract obstruction proven by 
echocardiography, a treatment with inotropic agents may be started with caution. Inotropic 
agents proposed are dobutamine or dopamine. Importantly, in patients with severe 
hypotension without significant left ventricle outflow tract obstruction but with severe left 
ventricular dysfunction, the use of an intra-aortic balloon pump is preferred to inotropic 
agents. Moreover, in patients with hypotension due to pump failure associated with a 
significant left ventricle outflow tract obstruction proven by echocardiography, a treatment 
with inotropic agents should not be started and the use of an intra-aortic balloon pump is 
recommended (Villareal et al., 2001; Sharkey et al., 2005). As mentioned above, β-blockers 
are recommended in patients with left ventricle outflow tract obstruction and fluid 
resuscitation is also recommended in the absence of congestive heart failure (Villareal et al., 
2001; Bybee et al., 2004).  In case of intolerance or inadequately response to β-blockers, use of 
an alpha agonist such as phenylephrine is proposed, used with caution and close 
monitoring due to its vasocontrictive effects (Reeder et al., 2010).  
10.1.2 Left ventricular thrombus 
Left ventricular thrombus must be detected in the acute phase. Short-term anticoagulation is 
indicated in this case and also in order to prevent its occurrence in patients with severe left 
ventricle systolic dysfunction. The anticoagulation is continued until left ventricular systolic 
www.intechopen.com
Tako-Tsubo Cardiomyopathy: 
A Recent Clinical Syndrome Mimicking an Acute Coronary Syndrome 
 
115 
function improves (Kimura et al., 2007; Haghi et al., 2008). Short-term anticoagulation is also 
prescribed in case of atrial fibrillation (Kimura et al., 2007). 
10.2 Chronic treatment 
Chronic treatment is rarely detailed and it also remains empirical. Chronic β-blockers are 
recommended in order to reduce the recurrence rate, in the absence of contraindications or 
intolerance (Prasad et al., 2008). However, several studies showed the partial efficacy of this 
therapy in order to prevent either the first episode or a recurrence of the TTC (Sharkey et al. 
2010; Parodi et al., 2010). Aspirin is not maintained even if the patient had a coexisting 
coronary atherosclerosis and angiotensin-converting enzyme inhibitors are not continued if 
the patient recovers left ventricle systolic function (Prasad et al., 2008; Bybee et al., 2004). 
11. Pathophysiology 
Several hypotheses have been proposed to explain TTC, but the precise mechanisms remain 
unclear. These pathophysiological hypotheses include: direct toxic effects of catecholamine 
excess on cardiomyocytes, coronary artery vasospasm, diffused coronary microvascular 
dysfunction and left ventricle outflow tract obstruction (Wittstein et al., 2005; Akashi et al., 
2010; Nef et al., 2007; Nef et al., 2007; Nef et al., 2009a; Nef et al., 2009b). 
11.1 Catecholamine excess 
Catecholamine excess following an emotional or physical stress is supposed to play an 
important role in the pathophysiology of the TTC and this mechanism is widely reported. 
Increased catecholamine levels promote microvascular spasm, damage and hypocontraction 
of the myocardial muscle responsible for the typical regional wall motion abnormalities. A 
mouse model demonstrated that catecholamine excess is responsible for a negatively 
inotropic effect (Heubach et al., 2004).  
The analysis of endomyocardial biopsies showed contraction band necrosis and 
mononuclear cell infiltrate, typically consistent with catecholamine excess. The apex of the 
left ventricle has an increase density of adrenoreceptors accounting for the apex being the 
most exposed to the cardiomyopathy. Moreover, there is a difference in the distribution of 
these adrenoreceptors among persons, which could explain the different variants of TTC 
(Hurst et al., 2006; Lyon et al., 2008; Litvinov et al., 2009).  
This neuro-hormonal hypothesis including catecholamine excess and exaggerated 
stimulation of the sympathetic nervous system is supported by several studies showing that 
patients with TTC have supraphysiologic and higher levels of plasma catecholamines than 
patients with acute coronary syndrome (Wittstein et al., 2005) 
Moreover, several cases have been described after administration of exogenous 
cathecolaminergic agents such as dobutamine (Previtali et al., 2005; Abraham et al., 2009; 
Cherian et al., 2008; Winogradow et al., 2010). However, other studies have documented no 
significant elevation in plasma catecholamine levels in TTC patients (Bybee et al., 2004; 
Gianni et al., 2006; Nef et al., 2007; Tsuchihashi et al., 2001; Kawai et al., 2007; Elesber et al., 
2007; Sharkey et al.,  2008; Blessing et al., 2007; Sharkey et al., 2007; Fazio et al., 2008). Thus, 
this pathophysiological mechanism is still debated.  
11.2 Coronary artery vasospasm 
Early reports have showed that TTC may be explained by coronary artery vasospasm, based 
on studies realising an induction of multi-vessel coronary spasm secondary to intra-
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coronary acetylcholine injection (Dote et al., 1991; Tsuchihashi et al., 2001). In fact, most of 
the patients in Japanese series exhibit a coronary epicardial spasm but it has been rarely 
described in the Caucasian population (Tsuchihashi et al., 2001; Kurisu et al., 2002; Bybee et 
al., 2004; Wittstein et al., 2005; Gianni et al., 2006).  
However, the duration of the TTC compared to a classical vasospasm and the regional wall 
motion abnormalities usually extending beyond a single vessel territory limit this theory of 
causal mechanism. Indeed, recent reviews consider that this mechanism is unlikely to be the 
underlying cause of TTC (Prasad et al., 2008; Tsuchihashi et al., 2001; Desmet et al., 2003; 
Kurisu et al., 2002; Yoshida et al., 2007; Abe & Kondo, 2003). 
11.3 Coronary microvascular dysfunction 
Largely abnormal coronary microvascular function is another pathophysiological 
mechanisms proposed. Reduced blood flow rates using TIMI frame count and spontaneous 
improvement of coronary flow reserve suggest a possible involvement of the microvascular 
function in the pathophysiology of the TTC (Previtali et al., 2005; Kimura et al., 2007; Haghi 
et al., 2008; Nef al., 2007; Nef et al., 2009). However, it has not yet been clearly defined 
whether microvascular dysfunction is a primary or secondary phenomenon (Bybee et al., 
2004; Yanagi et al., 2002; Barcin et al., 2003; Kume et al., 2005; Gibson et al., 1996). In fact, the 
coronary microvascular dysfunction could be the result of various causes, such as direct 
toxic effects of catecholamine excess and excessive sympathetic response or estrogen 
depletion (Kaski, 2006).  
Anyway, highlighting this pathophysiological mechanism, a recent study has demonstrated 
the key role of myocardial vasoconstriction in the etiopathogenesis of the TTC. For the 
authors, the typical regional wall motion abnormalities appear to be secondary to 
microvascular dysfunction, secondary to coronary microvascular vasoconstriction (Galiuto 
et al., 2010).  
However, data still remain controversial as another study showed that the akinetic 
territories involved were much larger than those affected by the coronary microvascular 
dysfunction. For the authors, even if coronary microvascular dysfunction is currently 
present during the acute phase of TTC, this may not be considered as the only 
pathophysiological mechanism of the cardiomyopathy (Fazio et al., 2010).  
11.4 Left ventricle outflow tract obstruction 
Left ventricle outflow tract obstruction has also been proposed to contribute to TTC 
pathogenesis. Published data showed that left ventricle outflow tract obstruction might be 
present in 11% of the TTC patients (Nef et al., 2010; el Mahmoud et al., 2008). Moreover, 
inotropic agents have been reported to induce or worsen left ventricle outflow tract 
obstruction.  
Consequently, such findings support a possible role of the left ventricle outflow tract 
obstruction in the pathogenesis of the TTC, but this pathogenic mechanism is still under 
debate.  
11.5 Myocarditis 
Another hypothesis has been proposed as a pathophysiological mechanism: myocarditis. 
Indeed, some cases have been reported to be associated with cardiotropic viruses (Bahlmann 
et al., 2007). However, the biopsy analysis of the myocardial muscle and the viral serology 
do not emphasize this pathophysiological mechanism (Silva et al., 2009; Abe et al., 2003).  
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11.6 Hormonal environment 
Last but not least, the cardiomyopathy usually occurs in postmenopausal women, 
highlighting the role of the hormonal environment and the protecting role of estrogens 
(Ueyama et al., 2003; Hinojosa-Laborde et al., 1999; & Celermajer, 2002; Connelly et al., 
2006). A case of TTC was described in a young woman suffering from an estrogen deficiency 
due to Turner syndrome. The woman had a low level of estrogens, as noted in 
postmenopausal women, explaining why she was more susceptible to TTC (Sato et al., 
2009). Moreover, an animal model with estrogen supplementation showed low occurrence 
of TTC (Ueyama et al., 2003).  
12. Conclusion 
Tako-Tsubo cardiomyopathy (TTC) is a syndrome which has recently gained increasing 
consideration. Typical presentation mimics acute coronary syndrome, with acute chest pain 
and/or dyspnoea, associated to electrocardiographic changes and moderate cardiac 
biomarkers release. The syndrome is characterized by a reversible left ventricle systolic 
dysfunction typically involving the apex, but in which coronary lesions are not involved. 
The transient regional wall motion abnormalities usually extend beyond a single vessel 
territory. 
It is important to note that patients with TTC may exhibit life-threatening acute phase and 
may require early and aggressive initial management.  
The pathophysiology of the syndrome remains still unclear and more research is needed in 
this area.  The diagnosis of TTC is most frequently made during coronary angiography, 
performed as recommended by the guidelines for the management of acute coronary 
syndrome.  
Patients with TTC may be exposed to inappropriate therapy such as thrombolysis, which 
may lead to serious complications, given the fact that coronary artery obstruction is not 
being involved. Thus, a good strategy seems to be the transfer of the patients suspected of 
TTC to a cardiac catheterization laboratory for emergency coronary angiography. 
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